Rheumatoid arthritis: current therapeutics compendium

Area of Science:

• Rheumatology
• Immunology
• Pharmacology

Background:

• Rheumatoid arthritis (RA) is a prevalent chronic inflammatory condition with significant patient and economic burdens.
• The multifactorial pathogenesis of RA necessitates advanced treatment strategies.
• Effective RA management aims to halt or slow disease progression.

Purpose of the Study:

• To review current therapeutic options for rheumatoid arthritis.
• To highlight the impact and advancements of biologic agents in RA management.
• To summarize novel biologic approaches driven by improved understanding of RA pathogenesis.

Main Methods:

• Literature review of current therapeutics for rheumatoid arthritis.
• Focus on the role and efficacy of biologic agents.
• Analysis of treatment outcomes in patients refractory to conventional therapies.

Main Results:

• Biologic agents have transformed RA management over the past two decades.
• These agents offer improved prognosis and clinical remission, particularly in non-responders to traditional DMARDs.
• Advancements in understanding RA pathogenesis have spurred the development of new biologic therapies.

Conclusions:

• Biologic agents represent a major advancement in rheumatoid arthritis treatment.
• Current therapeutics, especially biologics, offer significant benefits for patients.
• Continued research into RA pathogenesis promises further development of targeted biologic treatments.